Novartis India

71
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
2,004.10
-42.7 (-2.09%)
BSENSE

Sep 21, 03:59 PM

BSE+NSE Vol: 43.63 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -0.54% vs 6.33% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 2.93% vs 40.09% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 63.64% vs -48.32% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -7.65% vs 18.44% in Mar 2025

Compare Profit and Loss Results of Novartis India
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
354.00
165.00
189.00
114.55%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
354.00
165.00
189.00
114.55%
Expenditure (Ex Depriciation)
Stock Adjustments
-12.00
-9.00
-3.00
-33.33%
Raw Materials Consumed
210.00
30.00
180.00
600.00%
Power & Fuel Cost
0.00
31.00
-31.00
-100.00%
Employee Cost
21.00
14.00
7.00
50.00%
Operating Expenses
9.00
7.00
2.00
28.57%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
11.00
0.00
11.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
5.00
1.00
20.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
260.00
90.00
170.00
188.89%
Operating Profit (PBDIT) excl Other Income
94.00
75.00
19.00
25.33%
Other Income
38.00
2.00
36.00
1,800.00%
Operating Profit (PBDIT)
132.00
77.00
55.00
71.43%
Interest
1.00
2.00
-1.00
-50.00%
Profit before Depriciation and Tax
131.00
75.00
56.00
74.67%
Depreciation
1.00
12.00
-11.00
-91.67%
Profit Before Taxation & Exceptional Items
129.00
62.00
67.00
108.06%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
129.00
62.00
67.00
108.06%
Provision for Tax
36.00
15.00
21.00
140.00%
Profit After Tax
93.00
46.00
47.00
102.17%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
768.00
237.00
531.00
224.05%
Profit Available for appropriations
862.00
284.00
578.00
203.52%
Appropriations
862.00
284.00
578.00
203.52%
Equity Dividend (%)
500%
67%
433.00
Earnings Per Share
37.74
4.28
33.46
781.78%
Profit And Loss - Net Sales
Net Sales 354.33 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -0.54% vs 6.33% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 94.10 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 2.93% vs 40.09% in Mar 2025

Profit And Loss - Interest
Interest 1.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 63.64% vs -48.32% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 93.18 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -7.65% vs 18.44% in Mar 2025